Hakutulokset - Feng Bi

  • Näytetään 1 - 1 yhteensä 1 tuloksesta
Tarkenna hakua
  1. 1
    Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors

    Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors Tekijä Wenke Li, Menghui Xu, Mo Cheng, Jing Wei, Lin Zhu, Yu Deng, Fukun Guo, Feng Bi, Ming Liu

    Julkaistu 2025-07-01

    ABSTRACT Background Immunotherapy combined with chemotherapy has become the standard treatment for HER2‐negative gastric cancer (GC), but its clinical benefits remain limited, with a median progression‐free survival (mPFS) of 6–8 months and median overall survival (mOS) of 15–18 months. These outcom...

    Täydet tiedot

    Hae kokoteksti
    Artikkeli

    Lisää suosikkeihin
    Tallennettuna:

Työkalut: